VNT Stock Analysis: Vontier | NYSE
Scientific & Technical Instruments | NYSE, USA | Market Cap: 4.256m USD | 12M Return: -20% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 42.2M
EPS Trend: 69.4%
Qual. Beats: -1
Rev. Trend: -48.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Vontier Corporation (NYSE: VNT) is a global provider of mobility ecosystem solutions operating through three segments: Mobility Technologies, Repair Solutions, and Environmental and Fueling Solutions. The Mobility Technologies segment delivers digitally enabled equipment and software, including convenience retail operating platforms, point-of-sale and payment systems, remote diagnostics, EV charging network software, and IoT-based fleet telematics. The Repair Solutions segment manufactures and distributes aftermarket vehicle repair tools, diagnostic equipment, and software through a mobile franchise network. The Environmental and Fueling Solutions segment offers leak detection systems, forecourt controllers, vapor recovery equipment, and fuel dispensers under the Gilbarco and Veeder-Root brands, serving retail and commercial fueling, convenience store, and car wash operators worldwide.
Vontier was incorporated in 2019 and spun off from Fortive Corporation, completing its NYSE listing in October 2020 as a mid-cap industrial technology company. The business model combines equipment hardware sales with software and service revenue across the petroleum retail, commercial vehicle repair, and electric vehicle charging markets, serving customers in North America, Asia Pacific, Europe, and Latin America from its headquarters in Raleigh, North Carolina.
- EV charging software scales Mobility Technologies recurring revenue
- EPA fuel leak mandates drive Gilbarco Veeder-Root equipment demand
- Aftermarket repair margins expand on telematics and diagnostics software
| Net Income: 412.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.50 > 1.0 |
| NWC/Revenue: 7.64% < 20% (prev 17.76%; Δ -10.12% < -1%) |
| CFO/TA 0.11 > 3% & CFO 447.1m > Net Income 412.5m |
| Net Debt (1.74b) to EBITDA (675.3m): 2.58 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.5m) vs 12m ago -4.68% < -2% |
| Gross Margin: 46.54% > 18% (prev 47.31%; Δ -0.77% > 0.5%) |
| Asset Turnover: 73.24% > 50% (prev 69.04%; Δ 4.20% > 0%) |
| Interest Coverage Ratio: 9.40 > 6 (EBIT TTM 549.2m / Interest Expense TTM 58.4m) |
| A: 0.06 (Total Current Assets 1.27b - Total Current Liabilities 1.03b) / Total Assets 4.13b |
| B: 0.49 (Retained Earnings 2.02b / Total Assets 4.13b) |
| C: 0.13 (EBIT TTM 549.2m / Avg Total Assets 4.21b) |
| D: 0.44 (Book Value of Equity 1.26b / Total Liabilities 2.87b) |
| Altman-Z'' = 3.31 = A |
| DSRI: 0.97 (Receivables 559.1m/555.4m, Revenue 3.09b/2.96b) |
| GMI: 1.02 (GM 47.31% / 46.54%) |
| AQI: 1.02 (AQ_t 0.65 / AQ_t-1 0.64) |
| SGI: 1.04 (Revenue 3.09b / 2.96b) |
| TATA: -0.01 (NI 412.5m - CFO 447.1m) / TA 4.13b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of July 29, 2026, the stock is trading at USD 31.84 with a total of 1,832,362 shares traded. Over the past week, the price has changed by +6.88%, over one month by +10.90%, over three months by -11.60% and over the past year by -19.96%.
Current recommended Stop Loss: 30.80 (which is 3.3% or 1.3 ATR below the current price).
Vontier has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy VNT.
- StrongBuy: 5
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 39.7 | 24.7% |
P/E Trailing = 10.5331
P/E Forward = 8.7642
P/S = 1.3797
P/B = 3.3326
P/EG = 0.885
Revenue TTM = 3.09b USD
EBIT TTM = 549.2m USD
EBITDA TTM = 675.3m USD
Long Term Debt = 1.59b USD (from longTermDebt, last quarter)
Short Term Debt = 319.4m USD (from shortTermDebt, last quarter)
Debt = 1.98b USD (from shortLongTermDebtTotal, last quarter) + Leases 37.8m
Net Debt = 1.74b USD (calculated: Debt 1.98b - CCE 233.8m)
Enterprise Value = 6.00b USD (4.26b + Debt 1.98b - CCE 233.8m)
Interest Coverage Ratio = 9.40 (Ebit TTM 549.2m / Interest Expense TTM 58.4m)
EV/FCF = 16.07x (Enterprise Value 6.00b / FCF TTM 373.2m)
FCF Yield = 6.22% (FCF TTM 373.2m / Enterprise Value 6.00b)
FCF Margin = 12.10% (FCF TTM 373.2m / Revenue TTM 3.09b)
Net Margin = 13.37% (Net Income TTM 412.5m / Revenue TTM 3.09b)
Gross Margin = 46.54% ((Revenue TTM 3.09b - Cost of Revenue TTM 1.65b) / Revenue TTM)
Gross Margin QoQ = 44.66% (prev 46.27%)
Tobins Q-Ratio = 1.45 (Enterprise Value 6.00b / Total Assets 4.13b)
Interest Expense / Debt = 2.96% (Interest Expense 58.4m / Debt 1.98b)
Taxrate = 20.40% (105.7m / 518.2m)
NOPAT = 437.2m (EBIT 549.2m * (1 - 20.40%))
Current Ratio = 1.23 (Total Current Assets 1.27b / Total Current Liabilities 1.03b)
Debt / Equity = 1.57 (Debt 1.98b / totalStockholderEquity, last quarter 1.26b)
Debt / EBITDA = 2.58 (Net Debt 1.74b / EBITDA 675.3m)
Debt / FCF = 4.67 (Net Debt 1.74b / FCF TTM 373.2m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 412.5m / Total Assets 4.13b)
RoE = 33.42% (Net Income TTM 412.5m / Total Stockholder Equity 1.23b)
RoCE = 19.41% (EBIT 549.2m / Capital Employed (Equity 1.23b + L.T.Debt 1.59b))
RoIC = 13.39% (NOPAT 437.2m / Invested Capital 3.27b)
WACC = 7.96% (E(4.26b)/V(6.23b) * Re(10.57%) + D(1.98b)/V(6.23b) * Rd(2.96%) * (1-Tc(0.20)))
Discount Rate = 10.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.55 | Cagr: -3.92%
[DCF] Terminal Value 75.69% ; FCFF base≈370.4m ; Y1≈377.8m ; Y5≈413.1m
[DCF] Fair Price = 33.11 (EV 6.40b - Net Debt 1.74b = Equity 4.66b / Shares 140.8m; r=8.35% [WACC [floored]]; 5y FCF grow 1.91% → 2.50% )
EPS Correlation: 69.37 | EPS CAGR: 2.91% | SUE: -3.06 | # QB: -1
Revenue Correlation: -48.25 | Revenue CAGR: -1.28% | SUE: 0.46 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.80 | Chg30d=+0.78% | Revisions=-70% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.85 | Chg30d=+1.00% | Revisions=-42% | Analysts=7
EPS current Year (2026-12-31): EPS=3.41 | Chg30d=+0.56% | Revisions=-77% | GrowthEPS=+6.7% | GrowthRev=-1.4%
EPS next Year (2027-12-31): EPS=3.71 | Chg30d=+0.08% | Revisions=-79% | GrowthEPS=+8.6% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: -82% (up=2, down=35)